Hot Pursuit     26-Oct-17
Astec Lifesciences slumps after weak Q2 result
Astec Lifesciences lost 3.29% to Rs 548.70 at 13:36 IST on BSE after consolidated net profit dropped 40.27% to Rs 6.72 crore on 13.43% rise in total income to Rs 97.61 crore in Q2 September 2017 over Q2 September 2016.
The result was announced after market hours yesterday, 25 October 2017.

Meanwhile, the S&P BSE Sensex was up 19.45 points or 0.06% at 33,061.95. The S&P BSE Small-Cap index was up 126.84 points or 0.74% at 17,286.14.

On the BSE, 10,000 shares were traded on the counter so far as against the average daily volumes of 14,846 shares in the past one quarter. The stock had hit a high of Rs 559 and a low of Rs 535.55 so far during the day. The stock had hit a record high of Rs 694.80 on 20 December 2016 and a 52-week low of Rs 442 on 27 October 2016.

The stock had underperformed the market over the past one month till 25 October 2017, falling 5.37% compared with 4.57% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 3.59% as against Sensex's 2.04% rise. The scrip, however, outperformed the market in past one year, rising 22.91% as against Sensex's 18.70% rise.

The small-cap company has equity capital of Rs 19.52 crore. Face value per share is Rs 10.

Astec Lifesciences is a producer of agrochemicals and pharmaceutical intermediates.

Previous News
  Astec LifeSciences receives credit ratings for NCD programme
 ( Corporate News - 19-Jun-23   19:33 )
  Astec Lifesciences to discuss results
 ( Corporate News - 11-Oct-23   11:59 )
  Astec Lifesciences to pay final dividend
 ( Market Beat - Reports 03-May-22   11:43 )
  Board of Astec Lifesciences recommends Final Dividend
 ( Corporate News - 02-May-22   17:36 )
  Astec Lifesciences consolidated net profit declines 40.27% in the September 2017 quarter
 ( Results - Announcements 26-Oct-17   16:46 )
  Astec LifeSciences receives ratings action from ICRA
 ( Corporate News - 14-Mar-23   18:57 )
  Astec Lifesciences consolidated net profit declines 23.16% in the March 2021 quarter
 ( Results - Announcements 03-May-21   08:42 )
  Board of Astec Lifesciences accepts resignation of director
 ( Corporate News - 03-May-22   11:44 )
  Astec Lifesciences reports consolidated net loss of Rs 1.11 crore in the June 2019 quarter
 ( Results - Announcements 29-Jul-19   10:13 )
  Astec Lifesciences standalone net profit rises 65.49% in the December 2014 quarter
 ( Results - Announcements 02-Feb-15   11:26 )
  Astec Lifesciences to hold AGM
 ( Corporate News - 03-May-22   11:58 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top